Following an agreement with the Competition Commission, J&J will not enforce its TB drug patent in 134 countries and will reduce the drug price in South Africa.
Competition Commission and J&J reach TB drug agreement
Original Article by Linda Ensor | Business Day | 8 July 2024
Following an agreement with the Competition Commission, J&J will not enforce its TB drug patent in 134 countries and will reduce the drug price in South Africa.
More Posts
Mpox Cases in SA Rise as Local Transmission Accelerates
Mpox cases in South Africa are rising, mainly in the Western Cape. What the surge means for the healthcare industry.
Read more...
NHLS Scrambles as Pathology Services Funding Runs Dry
The NHLS is scrambling for new providers after funds for haematology pathology services ran dry, amid an R11.3bn provincial debt
Read more...
Momentum Group Posts Record Earnings
Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn – beating its R7bn Impact target a year early.
Read more...